Showing results (11-20 of 101) with videos related to

Sort By:
Pageof 11
Healthcare (Basel, Switzerland)|January 10, 2025
Unity in Diversity and Diversity in Unity-Vaccination Policies in EU CountriesElisaveta Petrova-Geretto, Alexandrina Vodenitcharova, Guenka Petrova
Expert Review of Pharmacoeconomics & Outcomes Research|April 7, 2020
'Without data, you're just another person with an opinion'Katarzyna Kolasa, Wim Goettsch, Guenka Petrova, et al.
Pharmacy Practice|August 26, 2014
Cost of outpatient hypertension pharmacotherapy: comparative study between Bulgaria and SerbiaAnna Ivanova, Dragana Lakic, Vesna Andric, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|December 20, 2013
Benefits of investment into modern medicines in Central-Eastern European countriesAndrás Inotai, Guenka Petrova, Dinko Vitezic, et al.
Healthcare (Basel, Switzerland)|July 2, 2021
Biosimilar Insulins and Their Impact on Prices and Utilization of Insulins in BulgariaKonstantin Tachkov, Zornitsa Mitkova, Petya Milushewa, et al.
Pharmaceuticals (Basel, Switzerland)|January 20, 2021
Did the Introduction of Biosimilars Influence Their Prices and Utilization? The Case of Biologic Disease Modifying Antirheumatic Drugs (bDMARD) in BulgariaKonstantin Tachkov, Zornitsa Mitkova, Vladimira Boyadzieva, et al.
Pharmaceuticals (Basel, Switzerland)|July 29, 2023
Study of Symptom Severity and Adherence to Therapy of Myelofibrosis Patients Treated with RuxolitinibVera Stoeva, Guenka Petrova, Konstantin Mitov, et al.
Social Psychiatry and Psychiatric Epidemiology|April 1, 2019
Costs and outcomes for individuals with psychosis prior to hospital admission and following discharge in BulgariaDesislava Ignatova, Maria Kamusheva, Guenka Petrova, et al.
Biotechnology, Biotechnological Equipment|May 29, 2015
Humanistic and economic aspects of haemophilia treatment in Bulgaria. Comparison between two therapeutic approaches: prophylactic vs. on-demand treatmentGuenka Petrova, Konstantin Tachkov, Svetla Georgieva, et al.
Pageof 11